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primary Hyperparathyroidism and Monoclonal Gammopathy 
Sudhaker Rao, MB, BS,* Rosella AntoneUi, MD,^  Kevin R. Kane, MD,* 
John E. Kuhn, MD,§ and Celina Hetnal, MDll 
Coexistent primary hyperparathyroidism and monoclonal gammopathy. although rare, has heen 
reported previously hy a numher of investigators. We report four patients with such an occurrence 
who were seen between 1976 and 1988. Anolher patient with primary hyperparathyroidism also had 
multiple myeloma and was In remission for 12 years. These patients represent approximately 1% of 
the 386 patients with primary hyperparathyroidism seen during the same 12-year period. Although 
several mechanisms have heen proposed to explain this concurrence. we believe it is the result of a 
chance occurrence. A review of the literature, an estimate of Ihe chance occurrence of coincidental 
monoclonal gammopathy. benign or malignant, in patients wtth primary hyperparathyroidism, and 
some practical implications of this interesting coexistence are presented. (Henry Ford Hosp Med J 
1991;39:41-4) 
c-gerM. Wl''"' 
I esearch. D*- I 
iiypha.se-
strinl 
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P rimary hyperparathyroidism (PHPT) and monoclonal gam-mopathy (MG) each can occur in association with a variety 
of other benign or malignant diseases (1-3). However, when 
these two conditions coexist, the resultant hypercalcemia and 
monoclonal protein spike can be misleading both from a diag-
nostic and management point of view. Although the presence of 
lypical lyfic bone lesions of multiple myeloma in a patient with 
hypercalcemia greatly facilitates the diagnostic evaluation, ab-
sence of such skeletal manifestations might complicate manage-
ment decisions. 
Between 1976 and 1988 we encountered four patients with 
PHPT and benign MG and one patient with PHPT and multiple 
myeloma. This report documents these five cases, reviews pre-
viously reported cases of coexistent PHPT and MG, discusses 
'ill- pixssible reason for this concurrence, and proposes recom-
mendations for management and adequate evaluation of such 
patients. 
Casel 
Case Reports 
A 62-year-old white man was found to have hypercalcemia during 
wspitalization for treatment of carpal tunnel syndrome. He denied any 
symptoms related lo either hypercalcemia or PHPT, His only com-
plaints included tingling and numbness related to carpal tunnel syn-
*ome, instability of the left ankle and foot as a result of remote sur-
tery, and pain in the righl hip. He was taking no medications known to 
Jtee hypercalcemia with thc exception of lithium carbonate which he 
" received for manic depression for 15 years, 
and^ '^ "'^  e'sctrolytes and creatinine, liver and thyroid function tests, 
coiTiplete blood count with differential count were normal. Semm 
J,,, "" '^sctrophoresis, performed as part of the evaluation of hyper-
Jlobu'''^ ' '^ ^^ '^'''""'^  'S'^ kappa monoclonal spike. Other immuno-
aliz '*'^ rQ wilhin the normal range. Skeletal survey .showed gener-
fHpr '^ '^^ '^ ^^ ^^  c^mt density without the specific lesions of either 
or myeloina. Bone mineral content at the mid-radius was nor-
mal. Advanced arthritic changes were noted in the lower spine and right 
hip. Bone marrow examination was negative for myeloma. Other perti-
nent investigations related to PHPT are summarized in Table 1. 
Discontinuation of lithium for one year, under close supervision, did 
not alter either serum calcium or indices of parathyroid function tests. 
Parathyroidectomy was advised but the patient reluctantly refused and 
agreed to regular follow-up. He subsequently underwent total right hip 
replacement and remains asymptomatic from hypercalcemia five years 
later Serial bone mineral measurements did not .show any decline and 
the MG remains unchanged. 
Case 2 
A 7.3-year-old black man with a four-year history of hyperten-
sion was incidentally found to have hypercalcemia. He acknowledged 
symptoms related to benign prostatic hypertrophy and atherosclerotic 
heart and aortic valvular disease but denied any symptoms related to 
hypercalcemia. Discontinuation of the thiazide diuretic that he was tak-
ing at the time hypercalcemia was discovered did not alter serum cal-
cium significantly. Further evaluation showed a normal serum protein 
electrophoresis, but an IgG lambda monoclonal spike was present on 
immunoglobulin electrophoresis. Urinary light chains were undetect-
able. Skeletal survey and bone scan were normal. Bone marrow aspi-
rate showed a slight increase in plasmacytes but was negative for my-
eloma. Serum electrolytes and creatinine and complete blood count 
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Table 1 
Parathvroid Function Studies 
Measurement Case 1 Case 2 Case 3 Case 4 Case 5 
Serum: 
Calcium (mg/dL) 11,0 11,2 11,3 10,8 1 1,1 
Phosphate (mg/dL) 2,7 2,6 2.5 2,9 2,1 
Creatinine (mg/dL) 1.0 1,3 1,0 l . l 1.2 
PTH (ng/mL) 13S 1,600 490 ')7 86 
Urine: 
NcAMP (nmol/dL GFR) 3.77 5,84 2,42 4,63 M) 
TmP/GFR (mg/dL) 1.73 1.86 1,45 2,43 Nl) 
Calcium (mg/24 hrs) 297 107 ND 267 
All values were confirmed by repeal measurements. 
PTH: < I.S0 ng/mL for cases 1-3, < 50 ng/niL for case 4, and < 40 ng/niL for case .s. 
PTH - parathyroid hormone. NcAMP - nephrogenous cyclic adenosine mono-
phosphate, GFR = glomerular filtration rate, TniP = renal phosphate threshold, ND = iicil 
done or nol available al the lime. 
with differential count were normal. Results of parathyroid function 
studies are summarized in Table I . 
The patient refused .surgery but agreed to be seen regularly. He was 
followed closely for three years during which a gradual increase in IgG 
component was noted (from 12.9 to 17.3 g/L [1.290 to 1.730 mg/dL], 
normal 7 to 16 g/L [700 to 1.600 mg/dL]). Small amounts of free 
lambda light chains were noted in the urine on two occasions, but sub-
sequent evaluations failed to detect these proteins. The mild anemia 
which developed (hemoglobin 118 g/L [1 1.8 g/dL]) was attributed to 
intermittent blood loss secondary to diverticulosis. 
The pattern was lost to follow-up for two years, but when he retumed 
the hypercalcemia and monoclonal protein spike were unchanged. He 
again refused parathyroidectomy and died suddenly of cardiac arrhyth-
mia five years after the initial detection of hypercalcemia and benign 
MG. Repeat bone marrow examination could not be done and an au-
topsy was not permitted. 
Case 3 
A 69-year-old black man was found to have hypercalcemia during 
hospitalization for an automobile accident. Serum protein electropho-
resis, performed as part of the evaluation for hypercalcemia, revealed 
an IgG lambda monoclonal spike. Quanlitative .serum immunoglob-
ulins were normal and no free light chains were seen in the urine. He 
was asymptomatic from hypercalcemia but had moderate dementia 
which was initially thought to bc related to his history of heavy alcohol 
abuse. Later, neurologic evaluation confirmed the presence of Alz-
heimer's disease. 
Serum electrolytes and creatinine, liver function tests, and complete 
blood count with differential count were normal. The skeletal survey 
was normal as was the bone mineral content at the mid-radius. Other 
pertinent laboratory investigations related to PHPT are shown in Table 
1. The patient was felt to be incapable of making a decision regarding 
parathyroidectomy, but his family remains undecided about surgical 
intervention in view of his lack of symptoms of hypercalcemia and the 
presence of significant dementia. He is currendy being followed at six-
month intervals and no change in serum calcium, creatinine, or immu-
noglobulin levels or bone density has been noted. His dementia has 
been stable over the past two years. 
Case 4 
A 79-year-old white woman was referred for evaluation of acciden-
tally discovered hypercalcemia. Two years previously she was diag-
nosed to have polymyalgia rheumatica (PMR) and had been receivij] 
corticosteroids. Serum calcium remained stable, unaffected by predni 
sone therapy. Iinmunoglobulin electrophoresis performed as part of (jJ 
evaluation of PMR showed an IgG kappa monoclonal spike, along wi*. 
elevated sedimentation rate and hypercalcemia. The skeletal sursJ 
was normal and bone marrow examination was not performed, NiJ 
years previously she had been seen by one ofus forevaluation of osten. 
porosis. Serum calcium, phosphate, creatinine, and parathyroid hor-
mone levels and bone density were normal and there was no evidence 
of osteoporosis. In the ensuing seven years she had remained asympto-
malic until she was found to have PMR, 
At the time of the recent evaluation she was asymptomatic from hy. 
percalcemia and the response of PMR to corticosteroid therapy was^ 
cellent. Results of the parathyroid function studies are summarized in 
Table 1. Parathyroidectomy was recominended. even though she is 
asymptomatic, because of her benign MG and the possible additional 
deleterious effects of corticosteroids on bone. 
Case 5 
A 54-year-old black man with hypertension was found lo have hy-
percalcemia during an annual screening test. Mild anemia (hemoglo-
bin 113 g/L [11,3 g/dL]) and proteinuria (1+) were also noted forthe 
first time. He was asymptomatic from hypercalcemia. An intravenous 
pyelogram. peribrmed as part of the evaluation of hypertension, re-
vealed the presence of a kidney stone in the lower pole of the left kid-
ney. Seruin protein electrophoresis showed increased gamma globu-
lins, and immunoglobulin electrophoresis revealed an IgG monoclonal 
spike with depression ofother immunoglobulins. Skeletal survey and 
bone scan were normal, as was the radial bone mineral content. Bone 
inarrow examination confirmed the diagnosis of multiple myeloma. 
Although Ihe parathyroid function studies were consislent with a 
diagnosis of PHPT (Table 1). neck exploration was deferred in ordet' 
to initiate treatment for myeloma. Therapy with adriamycin, cycll 
phosphamide. melphalan, and prednisone was commenced. Over the 
next six months the myeloma responded well to therapy and was judged 
to be in remission. During the same six-month period serial measure-
ments of serum calcium, phosphorus, creatinine, alkaline phosphatase, 
and immunoreactive parathyroid hormone levels remained unchanged, 
which is consistent with the equilibrium type of hypercalcemia of 
PHPT, Parathyroidectomy was recommended and a 7,.52 g adenoma 
was removed at surgery. Serum calcium was normal for the next 12 
years and multiple myeloina remained in remission wilh intermitteni 
chemotherapy. However, hypercalcemia recurred in association with 2 
pathologic fracture through a typical lytic lesion of myeloma in t i ^ 
right humerus. Unlike the previous episode of slable hypercalcemia. s6' 
rum calcium now fiuctuated widely between 2,99 and 3,99 inmol/Lfi^ 
and 16 mg/dL) and parathyroid hormone levels were suppressed. R| 
died eight weeks laler of pneumonia and sepsis. An autopsy was 
permitted. 
as no' 
Comment 
These five cases have in comtnon PHPT and MG, one 
whom also had mulfiple myeloma. Several other cases of sU 
concurrence have been reported (Tables 2 and 3). 
We have found 18 reported cases of PHPT and benign M G 1° 
which we add four cases (1,4-7). Three additional cases P ,^ 
were discovered during a retrospective analysis of patients * 
MG of unknown significance, but further details were not gt 
(3). It is unclear whether these three pafients were inclu 
I 
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Table 2 
Details of 22 Cases of PHPT and Benign MG 
Table 3 
Details of 13 Cases of PHPT and Multiple Myeloma 
Age/Sex/ Preoperative Surgical Follow-up 
1 MG. one ot 
cases of sucii I 
beniun MOW 
:asesofPHPT 
f patients vi* 
vere not gi^ "^^  
vere include'' 
III) 
-1(1) 
3(4) 
4(5) 
5(5) 
6(5) 
7(6) 
g(6) 
9(« 
1()|7) 
11(7) 
12(7) 
13(7) 
14(7) 
15(7) 
16(7) 
17(7) 
18(7) 
I9t 
20i 
2lt 
22t 
Race Imtnunoglobulin Calcium Findings Period* 
Details could nol be ascertained from the repon. 
Deiails could not be a.scertained from the report. 
.51/F/W IgG lambda 11,5 Adenoma 96 
62/M/B IgG kappa 13,5 Adenoma 12 
74/F/B IgG lambda 14,8 Hyperplasia 12 
68/F/B IgG lambda 14,6 Adenoma 5 
64/F/- IgA kappa 13,2 Adenoma NFU 
73/F/- IgG lambda 11,6 NOP NFU 
71/F/- IgA lambda 13,1 Adenoma NFU 
69/F/W IgG lambda 14.6 Adenoma 1 19 
73/F/W IgG kappa 13,7 Adenoma 7 
66/F/W IgG lambda 10.9 Adenoma 78 
55/M/W IgA kappa 11,2 Adenoma 80 
59/F/W IgG kappa 11.7 Adenoma 61 
72/F/W IgM kappa 13.3 Adenoma 60 
60/F/W IgG kappa l l . l Adenoma i'-l 
69/M/W IgA kappa 1 1.6 Adenoma 62 
52/F/W IgG kappa 12.2 Adenoma 60 
62/M/W IgM kappa 11.0 NOP •to 
73/M/B IgG lambda 12 2 NOP 60 
69/M/B IgG larnbda 1 1.3 NOP 36 
79/F/W IgG kappa 10,8 NOP 12 
-up period is i 1 months from the rime o diagnosis ot PHPT. 
tCurreiil tases. 
NFU = 110 follow-up dala given. NOP - nol operated. 
among the nine patients with PHPT and MG later reported from 
the same institution (7). 
Concurrent PHPT and multiple myeloma has also been re-
ported in 12 instances to which we add another case (1,2,7-13). 
Additional cases of coexistent PHPT and multiple myeloma 
have been referred to but no details were given (14). Hypercal-
cemia was an incidental finding in the ma jority of the patients in 
both groups (i.e., PHPT and benign MG, and PHPT and multiple 
myeloma). 
All pafients with PHPT and benign MG in whom information 
was provided were over .50 years old. This is consistent with the 
increasing prevalence of both diseases with advancing age (15, 
16). The preponderance of women (13 of the 19 cases. Table 2) 
reflects the increased prevalence of PHPT in women, even 
though benign MG is more common among men. Parathyroid 
pathology was an adenoma in 15 of the 16 cases (Table 2); this is 
similar to the findings in an unselected group of patients with 
PHPT (17). None of the pafients developed multiple myeloma, 
although follow-up was relatively short in a few cases (Table 2). 
Transient disappearance of monoclonal protein spike occurred 
one pafient, but it reappeared and remained stable over an 
i^ght-year follow-up (4,5). 
/^wessment of the age and sex distribufion among pafients 
*ith PHPT and multiple myeloma was difficult becau,se of the 
'^^ k of information in five of the 13 cases (Table 3). However, 
''"long those with sufficent informafion, females outnumbered 
""^ 'ss (six women versus two men). At surgery, an adenoma 
*as found in nine ofthe 10 pafients in whom parathyroid pathol-
ogy was reported (Table 3). An additional pafient probably had 
adenoma as assessed by a noninvasive method (8). Hypercal-
Case 
(Ref) 
Age/Sex/ 
Race Immunoglobulin 
Preoperative 
Calcium 
Surgical 
Findings 
I d ) ND ND ND 
'? Adenoma 
2(1) ND ND ND ? Adenoma 
3(1) ND ND NL) ? Adenoma 
4(1) NU ND ND Hyperplasia 
5(2) ND ND Nf) Adenoma 
6(7) 76/F/- IgG kappa l l . l Adenoma 
7(8) 45/F/W IgG lambda 17.1 Adenoma* 
8(9) 80/M/B Kappa chains 13.1 Adenoma 
9(10) 70/F/- Lambda chain 1 1,6 Adenomat 
10(1 1) 47/F/- IgA kappa 14,3 Adenoma 
11 (12) 51/F/- IgG lambda 11,9 Adenoma 
12(13) 74/F/W IgG kappa 12,0 Adenoma 
1-3* 54/M/B IgG lambda 11.2 Adenoma 
*By noninvasive method, 
tAulopsy findings. 
ijiCurrent case. 
ND = no deiails given. 
cemia remained stable and did not respond to the usual chemo-
therapy for myeloma in six patients (including our patient) in 
whom it was studied (7,8,10,12,13). This is consistent with the 
concept of equilibrium hypercalcemia of PHPT (18). Osteolyfic 
lesions of myeloma were present in three of the seven reported 
patients. A .second episode of hypercalcemia, presumably non-
parathyroid hormone mediated, has been documented in two 
cases (9.11). Our pafient with PHPT and myeloma illustrates 
such an occurrence 12 years after the diagnosis of myeloma and 
parathyroidectomy, emphasizing the need for continued surveil-
lance ofthese patients. Death ensued within two years of recur-
rence of hypercalcemia in all patients despite intensive chemo-
therapy. 
The nature of the coexistence of PHPT and benign MG and 
of PHPT and multiple myeloma is unclear. Although several 
mechanisms have been proposed, none are safisfactory (4-6). 
Based on available information and our own experience, the es-
timated prevalence is 0.6% to 1.0% for benign MG in PHPT and 
0.1% to 1.14% for myeloma in PHPT (1,7). Conversely, the 
prevalence is 1.2% for PHPT in benign MG and 0.1 % for PHPT 
in myeloma (3,19). Furthermore, the prevalence rates in the gen-
eral population for benign MG, mulfiple myeloma, and PHPT 
are approximately 1% to 3%, 0.1%, and 0.1% to 0.5%, respec-
tively (14-16). Given these various estimates, the concurrence 
of PHPT with either benign MG or myeloma appears to be coin-
cidental and conforms to the expected frequency. Our four pa-
tients with PHPT and benign MG and the patient with PHPT and 
myeloma were detected from among 386 cases of PHPT seen 
during the same 12-year period. An additional pafient with my-
eloma and probable PHPT was encountered among our pafients 
with PHPT but ful l confirmafion of PHPT was lacking. Thus 
the coexistence of benign MG or myeloma with PHPT in our 
population of pafients with PHPT is in agreement with other es-
fimates where a systemafic evaluafion of patients with hypercal-
cemia with .serum protein electrophoresis is performed (1,7). 
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Apart from this interesfing coexistence of PHPT with either 
benign MG or mulfiple myeloma, several important practical 
implicafions can be drawn from these cases. First, accidental 
discovery of hypercalcemia in an otherwise healthy individual 
is almost always due to PHPT and rarely to sarcoidosis or multi-
ple myeloma. All of our pafients were found to have hypercalce-
mia during routine biochemical screening and the MG was dis-
covered on further evaluation of hypercalcemia. We do not rou-
rinely perform serum protein or immunoglobulin electropho-
resis in patients with PHPT, and all five pafients reported here 
were referred to us after the initial electrophoresis had already 
been performed. Second, in the absence of other indicators of 
disease such as anemia, serum protein abnormalities, azotemia, 
and bone pain, routine studies of serum protein or immunoglob-
ulin electrophoresis do not appear to be jusfified in all patients 
with PHPT; the cost is high, the diagnostic yield is low, and the 
outcome is essentially unaffected. Third, presence of a mono-
clonal spike in a patient with stable hypercalcemia does not 
necessarily indicate myeloma nor a poor prognosis. Correc-
tion of PHPT-related hypercalcemia by parathyroidectomy, 
which was accomplished in our pafient with myeloma, alters the 
classification of the myeloma tumor mass and offers a favorable 
prognosis. Furthermore, hypercalcemia is not a feature of be-
nign MG. Fourth, elevated serum parathyroid hormone levels 
strongly indicate an underlying PHPT. There has not been a sin-
gle negafive neck exploration in any of the 30 patients with 
PHPT and benign MG or myeloma (Tables 2 and 3). A similar 
success rate has been reported in another group of patients with 
PHPT and presumed paraneoplastic hypercalcemia in whom 
nephrogenous cAMP was increased (2). Fifth, with the emer-
gence of mild asymptomafic PHPT as the major proportion of 
patients with PHPT, a conservative nonsurgical approach is 
being adopted by an increasing number of clinicians (20-22). 
While this approach is fully justified, parathyroidectomy is 
probably indicated in asymptomatic patients with PHPT when it 
coexists with benign MG and mulfiple myeloma. Parathyroid-
ectomy in such pafients subserves three important functions: it 
eliminates the confusion regarding the pathogenesis of hyper-
calcemia, alters the prognosis of concurrent myeloma, and pre-
serves the validity of hypercalcemia as a tumor marker in both 
benign MG and myeloma should hypercalcemia recur. 
Finally, it is important to distinguish "association" from 
"concurrence"; the former implies a cause-and-effect relation-
ship and the latter a simple chance occurrence. The probability 
of finding multiple diseases in hospital or clinic populations, 
compared to the general populafion, is increased because of se-
lection factors that are at work in such pafients (23). This phe-
nomenon has resulted in many reports of "associations" with 
PHPT, when in fact these are purely random events and tend to 
aggregate in hospital or clinic populations. It is therefore h^' 
ardous to draw conclusions about an "association" between tv^  
diseases in such populations. 
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